Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 2/20 | 0.44 |
| ▸ | FDPS | P14324 | 3/20 | 0.43 |
| ▸ | PPARG | P37231 | 1/20 | 0.40 |
| ▸ | PPARA | Q07869 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | MLNR | O43193 | 1/20 | 0.37 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.37 |
| ▸ | ESR1 | P03372 | 1/20 | 0.37 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.37 |
| ▸ | PGR | P06401 | 1/20 | 0.37 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.37 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.37 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.37 |
| ▸ | HTR1A | P08908 | 1/20 | 0.37 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.37 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.37 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Anisole SCHEMBL27997389 | 0.93 | CA4 (0.47) | LTA4HFDPSPPARGPPARAKMT2A | |
| SCHEMBL1527669 | 0.93 | PPARG (0.44) | LTA4HFDPSPPARGPPARAGAA | |
| SCHEMBL11065588 | 0.93 | PPARG (0.44) | LTA4HFDPSPPARGPPARAGAA | |
| SCHEMBL9453368 | 0.93 | PPARG (0.44) | LTA4HFDPSPPARGPPARAGAA | |
| SCHEMBL2391802 | 0.93 | PPARG (0.44) | LTA4HFDPSPPARGPPARAGAA | |
| SCHEMBL8745741 | 0.86 | PPARG (0.43) | LTA4HFDPSPPARGPPARAGAA | |
| SCHEMBL11874226 | 0.86 | PPARG (0.43) | LTA4HFDPSPPARGPPARAGAA | |
| SCHEMBL28021994 | 0.86 | PPARG (0.43) | LTA4HFDPSPPARGPPARAGAA | |
| SCHEMBL11870614 | 0.85 | LTA4H (0.57) | LTA4HFDPSMLNRNR1I2ESR1 | |
| SCHEMBL515722 | 0.85 | LTA4H (0.44) | LTA4HFDPSPPARGPPARAKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 281 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023185761-A1 | TRETINOIN AND BENZOYL PEROXIDE COMPOSITION, AND PREPARATION METHOD THEREFOR AND USE THEREOF | 南京毓浠医药技术有限公司 | 2023-10-05 | — | — | WO | claimed |
| CN-108603022-B | Polyalkylene oxide compositions | 住友精化株式会社 | 2023-03-28 | — | — | CN | claimed |
| CN-106687138-B | Vaccine pharmaceutical composition for cellular immunization comprising bisphosphonate agent | 日东电工株式会社 | 2021-10-15 | — | — | CN | claimed |
| CN-109835080-B | Single-coating direct-machining treatment-free CTP (computer to plate) | 安徽强邦新材料股份有限公司 | 2021-10-08 | — | — | CN | claimed |
| US-11046631-B2 | Diphenol and phenol prills and method for obtaining the same | RHODIA OPERATIONS (FR) | 2021-06-29 | — | — | US | claimed |
| US-10925936-B2 | Vaccine pharmaceutical composition for cell-mediated immunity containing bisphosphonates | NITTO DENKO CORPORATION (JP) | 2021-02-23 | — | — | US | claimed |
| EP-3544946-B1 | DIPHENOL PRILLS AND METHOD FOR OBTAINING THE SAME | RHODIA OPERATIONS (FR) | 2021-01-06 | — | — | EP | claimed |
| CN-111526892-A | Ophthalmic product and masking method | 狮王株式会社 | 2020-08-11 | — | — | CN | claimed |
| EP-3189854-B1 | VACCINE COMPOSITION FOR TRANSDERMAL OR TRANSMUCOSAL ADMINISTRATION | NITTO DENKO CORP (JP) | 2020-04-29 | — | — | EP | claimed |
| EP-3544946-A1 | DIPHENOL PRILLS AND METHOD FOR OBTAINING THE SAME | Rhodia Operations (FR) | 2019-10-02 | — | — | EP | claimed |
| US-20170360908-A1 | VACCINE PHARMACEUTICAL COMPOSITION FOR CELL-MEDIATED IMMUNITY CONTAINING BISPHOSPHONATES | NITTO DENKO CORPORATION (JP) | 2017-12-21 | — | — | US | claimed |
| EP-3189854-A1 | VACCINE PHARMACEUTICAL COMPOSITION FOR CELL-MEDIATED IMMUNITY CONTAINING BISPHOSPHONATES | Nitto Denko Corporation (JP) | 2017-07-12 | — | — | EP | claimed |
| CN-101962529-B | Soybean protein-calcium carbonate nano-adhesive as well as preparation method and application thereof | UNIV NANJING INF SCI & TECH | 2012-06-13 | — | — | CN | claimed |
| CN-101962529-A | Soybean protein-calcium carbonate nano-adhesive as well as preparation method and application thereof | UNIV NANJING INF SCI & TECH | 2011-02-02 | — | — | CN | claimed |
| EP-0743011-B1 | PROCESSED MEAT, MEAT MATERIAL USING THE SAME, AND METHOD OF PROCESSING MEAT | KATAYAMA KK (JP) | 2004-03-31 | — | — | EP | claimed |
| US-6352685-B2 | COMPRISING EXTRACT OF PUERARIA MIRIFICA, WHITENING AGENT, ANTI-OXIDANT, ANTI-INFLAMMATION AGENT, ULTRAVIOLET-RAY SHIELDING INGREDIENT | KOSé CORPORATION (JP) | 2002-03-05 | — | — | US | claimed |
| US-20010014311-A1 | External preparation for skin | SHIRATORI PHARMACEUTICAL CO., LTD. (JP) | 2001-08-16 | — | — | US | claimed |
| CN-1301543-A | Skin external use agent | KOSE CORP (JP) | 2001-07-04 | — | — | CN | claimed |
| EP-0743011-A1 | PROCESSED MEAT, MEAT MATERIAL USING THE SAME, AND METHOD OF PROCESSING MEAT | Kabushiki Kaisha Katayama (JP) | 1996-11-20 | — | — | EP | claimed |
| US-5143763-A | OXYGEN SCAVENGER | TORAY INDUSTRIES, INC. (JP) | 1992-09-01 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11046631-B2 | Diphenol and phenol prills and method for obtaining the same | DPM1, MCOLN3, TYR | LTA4H 2604/4885FDPS 125/4885PPARG 28/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.